Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
filingDate |
1994-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37d2979a6b7193cb8539b1d23b728a2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f330772016d5e628e66e49646550c017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87957ad3970e4cb3ccee39ac302a580f |
publicationDate |
1996-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-2727629-A1 |
titleOfInvention |
OSTEOPOROSIS TREATMENT CYCLE KIT |
abstract |
The invention relates to a kit for use in a therapeutic cycle based on the sequential administration of tiludronic acid or one of its salts and / or solvates and calcium for 28 to 31 days, for treatment and / or prevention. osteoporosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1790347-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004056373-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20041013-B1 |
priorityDate |
1994-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |